DNA bypass

Rechkoblit, O., Zhang, Y., Guo, D., Wang, Z., Amin, S., Krzeminsky,)., Louneva, N., and Geacintov, N.E. (2002) trans-Lesion synthesis past bulky benzo[a]pyrene diol epoxide N -dG and N6-dA lesions catalyzed by DNA bypass polymerases. J. Biol. Chem., 277, 30488-30494. 

It shows DNA damaged by the environmental chemical carcinogen benzo[ ]pyrene in the active site of the human DNA bypass polymerase k. 

The work of Loeb and Kunkel and their colleagues (70-72) has clearly established that apurinic sites in DNA are mutagenic they specifically cause transversion mutations, due to a strong preference for the incorporation of adenine residues during bypass of apurinic sites in template DNA. Thus, A T to T A and G C to T A transversions are the major mutagenic outcome generated by depurination of DNA. 

Under these circumstances, it may be unrealistic to expect research subjects to give scientists their DNA, family histories, and medical records for free. If the scientists are looking for millions, prospective research subjects may well wonder why their contribution should be uncompensated. On the other hand, it is extremely rare that any one individual research subject leads to a genetic breakthrough. Locating and cloning disease genes usually requires contributions of medical histories and DNA from thousands of subjects. Any one subject who held out for payment could be bypassed. 

Chaney SG, Vaisman A. DNA adduct tolerance and bypass. In (Kelland LR, Farrell N, eds) Platinum-Based Drugs in Cancer Therapy 2000 Humana Press Inc. Totowa, NJ pp. 129-148. 

Fusion with the cells compensates for this deficiency. When fused and unfused cells are incubated in the presence of the folic acid antagonist aminopterin, the de novo synthesis of purines and pyrimidines for DNA is blocked. Cells deficient in HGPRT die, whereas hybrid cells are able to bypass aminopterin blockage by metabolism of hypoxanthine and thymidine added to the medium. In the generation of mouse hybridomas, an number of myelomas deficient in HGPRT are available, all originating from MOPC 21, a spontaneous myeloma from the BALB/c mouse strain. 

FIGURE 26-7 Model for p-independent termination of transcription in f. coli. RNA polymerase pauses at a variety of DNA sequences, some of which are terminators. One of two outcomes is then possible the polymerase bypasses the site and continues on its way, or the complex undergoes a conformational change (isomerization). In the latter case, intramolecular pairing of complementary sequences in the newly formed RNA transcript may form a hairpin that disrupts the RNA-DNA hybrid and/or the interactions between the RNA and the polymerase, resulting in isomerization. An A=U hybrid region at the 3 end of the new transcript is relatively unstable, and the RNA dissociates completely, leading to termination and dissociation of the RNA molecule. This is the usual outcome at terminators. At other pause sites, the complex may escape after the isomerization step to continue RNA synthesis. 

In mammalian cells, at least eight DNA polymerases are present. DNA polymerase a is involved in the initiation of DNA synthesis at DNA replication origins and lagging strand synthesis (Wang, 1991). DNA polymerase 7is a mitochondrial DNA polymerase (Wang, 1991). Recently, bypass polymerases, such as DNA polymerase V, t. and Chave also been identified (Lindahl and Wood, 1999). These DNA polymerases are capable of continuing DNA synthesis even through bulky DNA lesions—such as UV-induced pyrimidine-dimers in the template strand (Lindahl and Wood, 1999). 

In this chapter, a brief overview of the cellular barriers to gene delivery is presented. Special emphasis is given to those events that compromise the translocation process of plasmid DNA from the cytosol into the nucleus. In addition, the strategies developed by viruses to efficiently bypass these cellular barriers and target their genomic DNA into the nucleus of infected cells will be discussed. 

Boudsocq, F., Iwai, S., Hanaoka, F., and Woodgate, R. (2001). Sulfolobus solfataricus P2 DNA polymerase IV (Dpo4) An archaeal DNA polymerase with lesion-bypass properties akin to eukaryotic pol q. Nucleic Acids Res. 15, 4607-4613. 

Ling, H., Boudsocq, F., Woodgate, R., and Yang, W. (2001). Crystal structure of a Y-Family DNA polymerase in action A mechanism for error-prone and lesion-bypass replication. Cell 107, 91-102. 

Zhou, B. L., Pata, J. D., and Steitz, T. A. (2001). Crystal structure of a DinB lesion bypass DNA polymerase catalytic fragment reveals a classic polymerase catalytic domain. Mol. CellS, 427-437. 

---